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Background: Viral encephalitis is a devastating condition for which delayed treatment is associated with increased
morbidity and mortality. Clinical audits indicate substantial scope for improved detection and treatment.
Improvement strategies should ideally be tailored according to identified needs and barriers to change. The aim of
the study is to evaluate the effectiveness and cost-effectiveness of a tailored intervention to improve the secondary
care management of suspected encephalitis.
Methods/Design: The study is a two-arm cluster randomised controlled trial with allocation by postgraduate
deanery. Participants were identified from 24 hospitals nested within 12 postgraduate deaneries in the United
Kingdom (UK). We developed a multifaceted intervention package including core and flexible components with
embedded behaviour change techniques selected on the basis of identified needs and barriers to change. The
primary outcome will be a composite of the proportion of patients with suspected encephalitis receiving timely
and appropriate diagnostic lumbar puncture within 12 h of hospital admission and aciclovir treatment within 6 h.
We will gather outcome data pre-intervention and up to 12 months post-intervention from patient records.
Statistical analysis at the cluster level will be blind to allocation. An economic evaluation will estimate intervention
cost-effectiveness from the health service perspective.
Trial registration: Controlled Trials: ISRCTN06886935.
Keywords: Encephalitis, Cluster randomised controlled trial, Guideline implementation, ProtocolBackground
There is evidence that the current clinical management
of serious acute neurological infections is suboptimal
[1-3]. Encephalitis, inflammation of the brain tissue, is
most commonly caused by herpes simplex virus in the
United Kingdom (UK) [4,5]. When herpes simplex virus
encephalitis is treated promptly with aciclovir, there is
a significant improvement in patient outcomes [6,7].
Encephalitis affects between five and eight people per
100,000 per year [8]. Sequelae after hospital discharge* Correspondence: r.backman@liverpool.ac.uk
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unless otherwise stated.can include significant morbidities such as epilepsy,
memory loss, and speech and behavioural disorders
[9,10], which also impair patients return to work [10].
Whilst herpes simplex virus encephalitis is relatively
rare [5], clinical presentations including features con-
sistent with suspected encephalitis occur relatively fre-
quently but in different ways to other brain injuries.
Encephalitis typically presents with one or more of
headache, fever, new-onset seizures, altered conscious-
ness, and behavioural disturbances [11]. This variable
and non-specific presentation often results in delayed
diagnosis, especially in children who may only present
with fever and irritability [12]. Furthermore, delays inal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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may further delay treatment [13-16].
Clinical guidelines have been developed in response to
these problems [1-3,5,17]. However, simple dissemination
of clinical guidelines is often unlikely to bring about sig-
nificant changes in clinical practice [18-20]. Further-
more, interventions to implement clinical guidelines
should ideally be based upon a diagnosis of barriers to
change, preferably focusing on those most amenable to
change [21].
Aims
We developed a multifaceted intervention package
including core and flexible components with embedded
behaviour change techniques selected on the basis of iden-
tified needs and barriers to change (Backman, submitted).
We will evaluate the effectiveness and cost-effectiveness of
a tailored intervention to improve the secondary care
management of suspected encephalitis.
Methods
Study design
Participating sites will be randomly allocated to interven-
tion or control (no intervention) arms in a cluster rando-
mised controlled trial.
Participants
Hospitals
This trial takes place in the context of ENCEPH UK—Un-
derstanding and Improving the Outcome of Encephalitis,
an ongoing research programme assessing the epide-
miology and clinical outcomes of encephalitis. In order to
reduce the likelihood of any unintended co-intervention
effects we sought hospitals not directly participating in
other ENCEPH UK studies. Sites had to have facilities to
perform lumbar punctures and neuroimaging and willing
to be randomised to intervention or control arms. We
aimed to recruit a range of types of hospital, providing
secondary, tertiary, (specialist) and paediatric care, to
broadly represent national provision and improve the
generalizability of subsequent findings.
We were aware that trainee doctors, one key target
intervention group, work and rotate between different
hospitals within postgraduate deaneries. If we randomised
hospitals to intervention and control arms within the
same deanery, there would be a risk of contamination. We
therefore used deaneries as the unit of randomisation to
minimise contamination.
We assessed all 266 acute trusts in England, Wales
and Scotland for eligibility (Figure 1 and Additional file 1
detail a full CONSORT checklist). After excluding 47 par-
ticipating in other ENCEPH UK studies and 10 specialist
hospitals not usually providing routine care for suspected
encephalitis patients, e.g. orthopaedic hospitals, we invited209 hospitals to participate via senior medical members of
staff.
Patients
We will identify records of patients with features sug-
gestive of suspected encephalitis using three sets of
criteria adapted from previous studies [1,22].
Method 1
Mandatory
 Acute or sub-acute (<4 weeks) alteration in
consciousness, cognition, personality or behaviour
persisting for more than 24 h. Personality/behaviour
change includes: agitation, psychosis, somnolence,
insomnia, catatonia, mood liability, altered sleep
pattern and (in children) new-onset enuresis or
irritability.
Plus any two of:
 Fever (≥38°C) or prodromal illness—acute or
sub-acute
 New-onset seizures
 Focal neurological signs of acute or sub-acute onset,
including focal weakness, oromotor dysfunction,
movement disorders (chorea, athetosis, dystonia,
hemiballismus, stereotypies, orolingual dyskinesia
and tics) including Parkinsonism (bradykinesia,
tremor, rigidity and postural instability) and amnesia
 Pleocytosis: cerebrospinal fluid white cell count of
more than four cells per microlitre
 Neuroimaging compatible with encephalitis
 Electroencephalogram (EEG) compatible with
encephalitis
Method 2
There was an initial clinical suspicion of encephalitis.
Method 3
There was a clinical suspicion of encephalitis, and the
patient died before investigations were completed.
Intervention package
Using theoretically informed semi-structured interviews
based upon the Theoretical Domains Framework [23,24],
we explored barriers and enablers to diagnosing and
managing patients with suspected encephalitis, specific-
ally performing lumbar punctures and initiating antiviral
therapy within 6 h (Backman, submitted). We mapped
identified barriers and enablers to the patient pathway.
We matched behaviour change techniques targeting
clinicians to the most salient barriers and enablers and
embedded them within an intervention package [25].
Figure 1 CONSORT 2010 checklist of information to include when reporting a cluster randomised trial.
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tions and, to allow for local flexibility, ‘optional’ interven-
tions (Table 1). We defined ‘core’ interventions as those
which we anticipated all hospitals being able to use.
These included educational and action planning meetings,
feedback of pre-intervention audit data and provision of
lumbar puncture kits within refillable boxes. We defined
‘optional’ interventions which hospitals could use depend-
ing upon local resources and skills. These included deci-
sion support via phone apps and algorithms, an online
quiz, prompts and posters, personalised invitation letters
to attend educational meetings and a quality improvement
cycle pack. Table 1 gives full details of the package follow-
ing the Template for Intervention Description and Repli-
cation (TIDieR) reporting guidance [26].
We presented the package to a 1-day meeting of senior
doctors and nurses from intervention hospitals. We
emphasised their roles in directly delivering the various
intervention components locally and recommended that
they each convene an action planning meeting on return
to their hospitals.Outcomes
The primary outcome is a composite measure of the pro-
portion of patients with suspected encephalitis whose care
meets both of the following criteria: aciclovir given within
6 h from admission to hospital and a lumbar puncture
performed within 12 h of hospital arrival unless clinically
contraindicated.
Secondary outcomes comprise:
 The proportion of all adults started on intravenous
aciclovir within an appropriate dosage range for a
neurological presentation who met the definition of
suspected encephalitis
 The proportion of all children started on
intravenous aciclovir within an appropriate dosage
range for a neurological presentation who met the
definition of suspected encephalitis
 The proportion of patients with suspected
encephalitis who had a lumbar puncture performed
within 12 h unless there was a clinical
contraindication
Table 1 Intervention description using the TIDieR guidelines for intervention reporting [26]
Intervention
component
Overview of component Materials Who provided Modes and frequency of
delivery
Whe it will take
plac
Tailoring
Training
day (core
component)
Investigators were invited to
attend a training day where
the intervention was
showcased and key behaviour
change techniques to be
communicated to their
trainees were highlighted
Senior clinicians were provided
with all the paper-based
intervention materials in a
bound form for reference.
Materials were also provided
in an electronic form for all
study team members
Key behaviour changes
and materials were
delivered by the study
team and a representative
from The Encephalitis
Society also shared their
patient journey
Delivered once per site at
the start of the intervention
Took ace in a central
locat with additional
local eetings as
requ d
Feedback from this session
led to the modification of
intervention materials to
make them more applicable
to each hospital
Action
planning
meeting (core
component)
Following training,
investigators were asked to
plan an implementation of
intervention components
A form was provided which
provided key topics to
discuss and plan around
Each local PI ran the
meeting
Training preceded this
meeting, and it was
requested that at least
one was held prior to
any educational sessions
With each hospital
with re team
mem rs
Sites could meet as frequently
as required
Audit and
feedback
newsletter (core
component)
An audit and feedback
newsletter was produced
with personalised data
alongside an action
planning element
Electronic and laminated
copies were provided which
contained personalised audit
data, a link to the guidelines
to promote action planning,
and space to add local clinical
leaders to add credibility
The study team
provided the materials
with the local clinical
leaders distributing to
their team
This was delivered
electronically and in hard
copy for distribution and
display alongside all other
intervention components
This l be displayed
with he hospital
near the other
com nents such
as th oster or the
guid e algorithm
This newsletter was personalised
to contain audit data from each
hospital. It also contained a
comparison with other
anonymised hospitals, as well
as to the recommended time
frames for care
Lumbar
puncture
box (core
component)
A refillable box with all
the key equipment to perform
a lumbar puncture was
provided with sample
collection information
which could be locally
modified as required
A box containing equipment
for the procedure alongside a
sheet detailing sample
collection was provided. Adult
and paediatric boxes were
available due to different
sample collection requirements
The study team
supplied 2–6 boxes
to each hospital as
required
Boxes were delivered at the
start of the intervention
period and on an ad hoc
basis
Boxe ere placed in
relev t locations as
desig ted by each
hosp l
The sample sheet could be
locally modified by each site to
accommodate sample
procedures
Pre-made lectures with
integrated behaviour change
techniques were produced for
the following uses: - A session
focused upon the diagnostic
lumbar puncture - A session
focused upon the management
of suspected encephalitis - A
session for nurses on how to
help with lumbar punctures
Pre-made lectures were
provided alongside a range
of other multimedia resources
including: - A DVD showing
nurses how to assist with the
procedure - Two clinical
vignettes - The Encephalitis
Society YouTube channel -
TS’ ‘Big Brain’ event on
YouTube
The study team
provided the resources
for the local team to
deliver as required
Sites were able to choose
the frequency of delivery,
with a recommended
minimum of one per
6 months
All tr ing will take
place ithin the
hosp l and will be
deliv d by clinicians
These materials can be locally
modified with a core set of
slides so preserve behaviour
change integrity. Furthermore,
these are all modified for use
in both an adult and paediatric
setting and can be used as
often as required by the local
team
Educational
survey (optional
component)
An online multiple choice
educational survey was
developed with tailored
questions for doctors and
nurses. This online tool can
be accessed at any time and
all participants can download
a certificate of completion
An online multiple choice
educational survey was
developed. A certificate of
completion was awarded
with additional checklists
and action planning tools
Site PIs were able to
circulate this online
link to all junior doctors
The trainee would only
complete the survey
once with a certificate
of completion
This uld take place
durin a teaching
sessi or during
priva study
Two surveys were available
with questions tailored for
doctors and nursing staff
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Table 1 Intervention description using the TIDieR guidelines for intervention reporting [26] (Continued)
ClickClinica
[27] (optional
component)
An app containing all current
guidelines was developed.
This has been promoted
within our package both
within the education and also
within the personalised
invitation letter as a useful tool
An app has been developed
for use with iPhones whereby
all guidelines are available in
one place
This app was promoted
through local clinical
leaders
The link to download the
app was within the
educational sessions and
contained within the
direct mail letter
Guid es can be
chec and
dow ded on the
ward within private
stud
None available for this
component
Encephalitis
Society leaflets
and video
(optional
component)
The Encephalitis Society
YouTube channel was
included as a resource which
could be incorporated into the
education. Furthermore,
patient leaflets will be
disseminated to the
investigators during the study
Printed materials for the
patients and healthcare
professionals were provided.
These materials were also
featured within the
educational sessions
These were provided by
The Encephalitis Society,
forwarded by the study
team and disseminated
by the local clinical
leaders
These were provided at the
start and middle of the
intervention period with
reinforcement from the
educational sessions
The Tube videos
coul used during
the e ational session
or w a private
stud ssion as part of
a cri reflection
None available for this
component
A quality improvement cycle
(plan, do, study, act (PDSA))
was developed and included: -
A summary page with the key
guideline recommendations -
A short list of key check box
items to monitor current
practice - An excel sheet
which pre-plots the progress
Printed packs were provided
alongside an electronic excel
sheet with pre-plotting graphs
to enable feedback
The study team provided
all materials and these
were locally disseminated
by the clinical leader
Electronic materials were
provided at the start of the
study with printed materials
provided within the 6-month
update. Local clinical leaders
were encouraged to ask a
junior doctor to assess current
management and feedback
performance data
With he ward where
the l l PI is based as
part post-take
ward nd. The qual-
ity im vement
grap hould also be
displ d within this
area
Junior doctors are able
to feedback the areas of
compliance they feel are
most relevant to the
department
Basis of
modifiable
care pathway
(optional
component)
The front sheet from the
quality improvement cycle
could also be modified to
form the basis of a care
pathway for suspected
encephalitis patients. This
will be locally driven and
implemented at each site
A traffic light coloured sheet
with the critical patient
management items was
provided as a basis to modify
The study team
provided the resource
and it was then
adapted by the local
clinical team
This was provided once at
the start of the intervention
Loca nical leaders
will m ify and display
in ke eas of the
hosp
This sheet was to be locally
adapted if taken up
Algorithm
(optional
component)
The algorithm contained
within the guidelines was
reproduced with two
additional features; a QR
code which links directly to
the guidelines and a box
that contained details for
local senior support
A laminated guideline
algorithm was provided with a
QR code to link to the original
guidelines and a space for
local modification with the
additional of a local contact
The study team provided
the materials, and they
were disseminated
throughout the hospital
by the local clinical team
A minimum of five were
provided to each site at the
start and a further five were
also provided after 6 months
Thes ill be placed in
key a s of the
hosp as denoted by
the l l clinical leader
These are available in adult
and paediatric forms and can
be locally modified by the
addition of a suitable contact
if clinical decision support is
required
Posters
(optional
component)
Posters with key symptoms
and relevant QR codes were
designed and graphics
covered paediatric, adults
and geriatrics
Three posters were provided
to cover a variety of ages
alongside the key clinical
symptoms. A QR code to the
guideline was also
incorporated
The study team provided
the materials, and they
were disseminated
throughout the hospital
by the local clinical team
A minimum of five were
provided to each site at the
start, and a further five were
also provided after 6 months
Thes ill be placed in
key a s of the
hosp as denoted by
the l l clinical leader
None available for this
component
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Table 1 Intervention description using the TIDieR guidelines for intervention reporting [26] (Continued)
Stickers
(optional
component)
Small stickers with ‘Think brain
infection’ were produced for
application to blood sample
bottles
‘Think brain infection’
stickers were provided to
raise awareness during the
sample taking procedure
The local study team
provided these on an
ad hoc basis and the
local clinical leaders
affixed these to sample
bottles as required
These were provided on
an ad hoc basis with
supplements sent within
the 6-month update
These will be added
to all relevant bottles
as denoted by the
study team
None available for this
component
Invitation letter
(optional
component)
A template invitation letter
from the consultant inviting
the junior doctor to attend
each of the education session
was developed for local
modification. Details of the
lumbar puncture box and
ClickClinica were also included
An electronic letter was
made for each of the
educational sessions
The study team
provided the basis of a
letter which will then
be modified and sent
by the consultant
This invitation letter can
be sent prior to all
educational sessions
Letters will be sent
directly to the junior
doctors to personally
invite them to attend
the educational session
The basis of the letter
was provided for local
modification
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Table 2 Sample size estimates for the trial
Number of eligible patients
recruited per hospital (M)
Proportion meeting the primary
outcome criteria under the
intervention (P)
0.15 0.20 0.25
10 0.487 0.707 0.845
15 0.547 0.777 0.907
20 0.590 0.809 0.921
25 0.606 0.832 0.937
Backman et al. Implementation Science  (2015) 10:14 Page 7 of 9 The proportion of patients with suspected
encephalitis who had a lumbar puncture at any
point during the index presentation
 The proportion of patients with suspected
encephalitis who had either magnetic resonance
imaging (MRI) or computer tomography (CT) scan
within 24 h of admission
 The proportion of patients with suspected
encephalitis having had a lumbar puncture, who had
the following cerebrospinal fluid (CSF) investigations
performed: ratio of glucose within the cerebrospinal
fluid and the serum calculated and having herpes
simplex virus polymerase chain reaction (PCR)
performed
We will also compare outcomes between adults and
children.
Data collection
We recognise that suspected cases would go through
one or more of several types of hospital department but
mainly paediatrics, neurology, infectious diseases, medical
assessment unit, accident and emergency and micro-
biology. Staff in participating hospitals will identify sus-
pected cases retrospectively by performing two mandatory
searches, of discharge codes for encephalitis in the preced-
ing 12 months and of all patients undergoing a lumbar
puncture within the same time period. Hospitals can also
find eligible patients via records of intravenous aciclovir
prescriptions or of orders for cranial CT scan or MRI
within the last 12 months. We are using these combined
approaches to maximise likelihood of case identification
and reduce differences in ascertainment between hospi-
tals. We included both adult and paediatric cases.
Pre-intervention, we collected data to pilot outcome
measures and provide data for the feedback intervention.
We aimed for 30 adult and paediatric cases per hospital
to allow for possible under-recruitment in some of the
smaller hospitals; however, we later sought some add-
itional cases from higher recruiting hospitals to better
inform exploratory analyses of the baseline data and to
compensate for lower recruiting sites. We plan to ask
for a further 30 cases per hospital in the final trial data
collection, thus the total patient sample size will be a
maximum of 720. We anticipate a degree of imbalance
between hospitals to achieve the total required sample
size, limited by the upper limit of 40 cases per hospital.
Data are collected using structured case review forms.
No patient identifiable information is sent to the central
trial team. We trained data collectors, mainly nurses and
trainee doctors, via face-to-face meetings and/or written
briefing materials. We emphasised the need for a system-
atic approach to case identification to reduce the likeli-
hood of selection bias. The trial research fellow (RB) ismonitoring fidelity to the intervention via regular tele-
phone and email contact with relevant hospitals. She is
also collecting qualitative data from staff interviews and
observational field notes in a sub-sample of four interven-
tion hospitals data as part of a process evaluation.
Sample size
Using pilot data from 315 patients across 26 hospitals in
four deaneries, we estimated the standard deviations of
the deanery and hospital random effects to be 0.244 and
1.108, respectively, and the current proportion of adher-
ence to the primary outcome to be 5%. Table 2 shows
the power of the likelihood ratio test for a significant
difference between intervention and control arms as a
function of m, the number of eligible patients recruited
per hospital, and p, the proportion meeting the primary
outcome criteria under the intervention. Using these es-
timates and based upon a total of 24 hospitals, recruiting
20 patients per hospital should achieve a power of at
least 0.8 when the compliance proportion under the
intervention is 0.20.
Randomisation
As explained above, we used deaneries as the unit of
randomisation to minimise contamination between hos-
pitals within the same deanery. We defined two blocks
of deaneries, a block of six including hospitals (outside
of the trial) where research teams were already actively
involved in other ENCEPH UK studies and a block of
six where there were no such ongoing studies (Figure 1).
An independent statistician randomised equal numbers
of clusters within each block to the intervention and
routine arms, blinded to hospital identity.
Statistical analysis
We will analyse the results in R (www.r-project.org)
using a generalised linear mixed model [28] with bino-
mial errors, logistic link, fixed effects for blocks and
treatments, random effects for deanery and for hospital.
If the intervention is effective, it will raise awareness of
suspected encephalitis and lead to increased documenta-
tion in the clinical records of encephalitis as a differen-
tial diagnosis. In our baseline (pre-intervention analysis),
Backman et al. Implementation Science  (2015) 10:14 Page 8 of 9we found that cases mainly included on this basis (method
two) tended to be less likely to comply with the primary
outcome criteria. One explanation is that these may re-
present clinical presentations at lower risk of having
encephalitis and may therefore tend to be investigated and
treated less thoroughly compared with more strongly sus-
pected cases. It is therefore likely that the intervention will
result in differential case mixes between the intervention
and control arms, in this scenario diluting any real inter-
vention effect. In our analysis of the outcome data, we will
adjust for any relationship between the method of inclu-
sion and compliance with the primary outcomes and ana-
lysis will be undertaken by a statistician blind to hospital
assignment.Cost-effectiveness analysis
The economic evaluation will take the perspective of the
UK National Health Service (NHS). We will use trial
records and observations to estimate the costs of interven-
tion delivery. Data on health care resource utilisation will
be gathered from case record reviews. Unit costs will be
obtained from publicly available routine data [29,30].
Costs and health benefits occurring over 12 months will
be discounted at 3.5% per annum. Therefore, results will
include, in addition to incremental costs and benefits, an
estimate of total cost per patient for each arm. In order to
estimate quality-adjusted life years (QALYs), utility values
will be estimated from the results of administering the
EQ-5D, primary economic outcome, and the SF-6D utility
scores derived from the SF-36, following Brazier’s method-
ology [31].
We will analyse cost data using regression methods for
handling censored cost data and accounting for clustered
nature of the data [32]. We will analyse costs and benefits
jointly using a bivariate probability distribution. Sample
uncertainty in estimated cost difference and incremental
cost-effectiveness ratios between arm groups will be de-
scribed using bootstrapped confidence intervals [33] as
well as with cost-effectiveness acceptability curves. Par-
ameter uncertainty and robustness of findings will be
accounted for through univariate sensitivity analysis and
probabilistic sensitivity analysis.
Estimates of costs and health outcome (utilities) will be
used to populate a model of suspected encephalitis patient
management in both intervention and control conditions.
The model will cover the remaining patient lifetime within
which the (probability of) cost-effectiveness of the alterna-
tive will be analysed [34]. Data analysis will be performed
using Stata [35].Ethical review
The study was reviewed by Preston North West Research
Ethics Committee (13/NW/0279) (Additional file 2).Trial status
The trial is ongoing with pre-intervention data collection
completed; we are yet to undertake post-intervention
outcome data collection and analysis.
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Additional file 1: CONSORT 2010 checklist of information to include
when reporting a cluster randomised trial.
Additional file 2: Confirmation of ethical approval.
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